Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Clinical Trials
Collaboration
Funding
Clinical Trial
Caris Life Sciences embarks on 10K-sample breast cancer biomarker analysis project
By
LabPulse.com staff writers
Caris will perform comprehensive molecular characterization of TAILORx tissue samples.
October 25, 2024
BioAffinity secures $2.7M to advance novel lung cancer diagnostic test
By
LabPulse.com staff writers
Texas-based bioAffinity Technologies has secured nearly $2.7 million at the close of a registered direct stock offering that it will use for general corporate purposes, including working capital, to advance its novel CyPath Lung test.
October 24, 2024
Twist Bioscience enters deal for $15M million cash upfront
By
LabPulse.com staff writers
Synthetic biology and genomics company Twist Bioscience has entered a deal with Xoma Royalty Corporation.
October 22, 2024
Multiregional clinical trial data on FDA watch for U.S. applicability
By
LabPulse.com staff writers
Pivotal trials drawing on foreign clinical data in focus.
September 16, 2024
Qiagen ventures into chronic disease CDx
By
LabPulse.com staff writers
Qiagen has expanded its agreement with AstraZeneca beyond oncology.
August 29, 2024
Accelerate Diagnostics completes preclinical trial for antimicrobial test system
By
LabPulse.com staff writers
Accelerate Diagnostics successfully completed the preclinical trial of its WAVE antimicrobial susceptibility testing system.
August 12, 2024
Invenio enrolls 1st patients in AI-based lung cancer image analysis study
By
LabPulse.com staff writers
Invenio Imaging has begun enrolling patients in a pivotal study of its artificial intelligence (AI)-based image analysis module for lung cancer.
August 9, 2024
FDA stops BioNTech MediLink study due to 'significant risks,' adverse events
By
LabPulse.com staff writers
Conducted in both the U.S. and China, the YL202 study aimed to evaluate the safety and tolerability of the ADC as a later-line treatment for some cancers.
June 18, 2024
Immunovia announces positive results for next-gen pancreatic cancer test
By
LabPulse.com staff writers
Diagnostics company Immunovia announced positive results for the newest generation of its pancreatic cancer test from a model-development study, announcing that the test achieved both its primary and secondary endpoints.
April 25, 2024
Castle Biosciences shares melanoma test study data at SSO 2024
By
LabPulse.com staff writers
Castle Biosciences shared data from two studies on the performance of its DecisionDx-Melanoma test in patients with cutaneous melanoma at the Society of Surgical Oncology 2024 (SSO 2024) annual meeting, held March 20-23 in Atlanta.
March 26, 2024
ChromaCode partners with the Medical College of Georgia on NSCLC assay validation
By
LabPulse.com staff writers
ChromaCode announced a partnership with the Medical College of Georgia to test the analytical and clinical performance of ChromaCode's HDPCR non-small cell lung cancer (NSCLC) biomarker assay.
March 21, 2024
Novartis presents first results of SMART spinal muscular atrophy study
By
LabPulse.com staff writers
Company presents new data from a clinical study, called the SMART study, of its gene therapy in previously treated patients and a broader patient population.
March 5, 2024
Page 1 of 19
Next Page